P2RY8: A Potential Drug Target and Biomarker (G286530)

Target Name: P2RY8

NCBI ID: G286530

P2RY8

P2RY8: A Potential Drug Target and Biomarker

P2RY8 (MGC50878) is a protein that is expressed in various tissues and cell types in the human body. It is a member of the P2Y family of G protein-coupled receptors, which are involved in cellular signaling and inflammation. P2RY8 has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and psychiatric conditions.

P2RY8 and its Functions

P2RY8 is a 12-kDa transmembrane protein that is expressed in various tissues, including brain, heart, skeletal muscles, and pancreatic ductal peptide-producing cells. It is a member of the P2Y family of G protein-coupled receptors, which are involved in cellular signaling and inflammation. The P2Y family of receptors consists of four isoforms: P2Y1, P2Y2, P2Y4, and P2Y5. P2Y8 is one of the isoforms that has been identified as a potential drug target and biomarker.

P2RY8 is involved in various physiological processes in the body, including cell signaling, neurotransmitter release, and inflammation. It is involved in the regulation of pain perception, inflammation, and neurotransmission. P2RY8 has been shown to play a role in pain perception and neurotransmission, with studies showing that it is involved in the modulation of pain signals in the brain.

P2RY8 has also been shown to be involved in the regulation of neurotransmitter release, including the release of serotonin and dopamine. It is known to be involved in the regulation of neurotransmitter release from postsynaptic terminals, and its function in this process is still not well understood.

In addition to its role in neurotransmission, P2RY8 is also involved in the regulation of inflammation. Studies have shown that P2RY8 is involved in the regulation of inflammation in various tissues, including brain and pancreatic ductal peptide-producing cells.

P2RY8 as a Potential Drug Target

P2RY8 has been identified as a potential drug target due to its involvement in various physiological processes that are important for human health. P2RY8 has been shown to play a role in the regulation of pain perception, neurotransmission, and inflammation, making it a promising target for drug development.

P2RY8 has been shown to be involved in the regulation of pain perception, with studies showing that it is involved in the modulation of pain signals in the brain. Its role in pain perception is thought to be related to its involvement in the regulation of neurotransmission, including the release of pain signals.

P2RY8 has also been shown to be involved in the regulation of neurotransmission, including the release of serotonin and dopamine. Its role in neurotransmission is thought to be related to its involvement in the regulation of neurotransmission from postsynaptic terminals.

In addition to its involvement in neurotransmission, P2RY8 has also been shown to be involved in the regulation of inflammation in various tissues, including brain and pancreatic ductal peptide-producing cells. Its role in inflammation is thought to be related to its involvement in the regulation of immune responses.

P2RY8 as a Potential Biomarker

P2RY8 has also been identified as a potential biomarker for various diseases, including cancer, neurodegenerative disorders, and psychiatric conditions. Its potential as a biomarker is due to its involvement in various physiological processes that are important for human health.

P2RY8 has been shown to be involved in the regulation of pain perception, with studies showing that it is involved in the modulation of pain signals in the brain. This makes it a potential biomarker for

Protein Name: P2Y Receptor Family Member 8

Functions: Probable receptor for purines coupled to G-proteins

The "P2RY8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about P2RY8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets